Filing Details

Accession Number:
0001237899-12-000071
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-08-27 18:13:55
Reporting Period:
2012-08-23
Filing Date:
2012-08-27
Accepted Time:
2012-08-27 18:13:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
872589 Regeneron Pharmaceuticals Inc REGN Pharmaceutical Preparations (2834) 133444607
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1403178 S Douglas Mccorkle 777 Old Saw Mill River Road
Tarrytown NY 10591
Vp Controller And Asst Treasur No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-08-23 5,875 $30.63 5,875 No 4 M Direct
Common Stock Disposition 2012-08-23 1,268 $141.85 4,607 No 4 F Direct
Common Stock Disposition 2012-08-23 2,122 $141.85 2,485 No 4 F Direct
Common Stock Acquisiton 2012-08-23 9,250 $21.25 11,735 No 4 M Direct
Common Stock Disposition 2012-08-23 1,385 $141.85 10,350 No 4 F Direct
Common Stock Disposition 2012-08-23 3,623 $141.85 6,727 No 4 F Direct
Common Stock Disposition 2012-08-24 200 $142.71 6,527 No 4 S Direct
Common Stock Disposition 2012-08-24 4,178 $144.67 2,349 No 4 S Direct
Common Stock Disposition 2012-08-24 2,149 $145.22 200 No 4 S Direct
Common Stock Disposition 2012-08-24 200 $146.07 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 M Direct
No 4 F Direct
No 4 F Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-08-23 9,250 $0.00 9,250 $21.25
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2012-08-23 5,875 $0.00 5,875 $30.63
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,873 2019-12-18 No 4 M Direct
14,305 2020-12-14 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 4,264 Indirect By 401(k) Plan
Footnotes
  1. Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
  2. Represents volume-weighted average price of sales of 200 shares of Company stock on August 24, 2012 at prices ranging from $142.55 to $142.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2012 at each separate price.
  3. Represents volume-weighted average price of sales of 4,178 shares of Company stock on August 24, 2012 at prices ranging from $144.11 to $144.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2012 at each separate price.
  4. Represents volume-weighted average price of sales of 2,149 shares of Company stock on August 24, 2012 at prices ranging from $145.00 to $145.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2012 at each separate price.
  5. Represents volume-weighted average price of sales of 200 shares of Company stock on August 24, 2012 at prices ranging from $146.00 to $146.14. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 24, 2012 at each separate price.
  6. The stock option award (combined incentive stock option and non-qualified stock option) vests in four equal annual installments, commencing one year after the date of grant.
  7. Exercisable date, exercise date, exercise price, purchase price, sales price, and/or expiration date is/are not applicable in this case.